HNB General Insurance Appoints Dilshan Perera as Chief Operating Officer Michael Jacksons Off the Wall Album Surges to New Heights on Billboard Charts Decades After Release April Jobs Report Preview Labor Market Shows Cooling but Resilient Trends European AI Stocks Surge Over 100 in Blockbuster Rally This Year WSJs Heard on the Street Launches Eighth Annual StockPicking Competition Oil Prices Decline as USIran Peace Deal Hopes Rise Strait of Hormuz Reopening Possible Euronet Worldwide EEFT Q1 2026 Earnings EPS Beat Drives Nuanced Outlook Amid Broader Market Headwinds Consensus Cloud Solutions Inc CCSI Q1 2026 Earnings EPS Beats Estimates by 743 as Stock Rises Metallus MTUS Q1 2026 Earnings EPS Beat Highlights Cost Discipline Amid Revenue Headwinds SUPER HI INTERNATIONAL HOLDING LTD HDL Q4 2025 Earnings Limited Financial Disclosure EPS of 010 Reported Masco Corporation MAS Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction AQMS Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges for PreRevenue Company Highview Merger Corp HVMC Holds Steady Near Trust Value Amid Merger Anticipation Research Solutions Inc RSSS Tests Key Support Zone After Modest Decline Ultragenyx RARE Pushes Higher on Positive Clinical Momentum Key Levels to Watch Fair Isaac FICO Holds Near Support Amid Modest Gains Rising Dragon Acquisition Corp RDAC Holds Steady Near 930 Amid SPAC Uncertainty South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Tensions FGBIP Q1 2026 Earnings Strong EPS Beat Amid Quiet Market Reaction Otis Worldwide OTIS Edges Higher Key Levels to Watch After a 159 Gain CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent KGEI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions AZN Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operational Results IEP Q1 2026 Earnings Wide EPS Miss as Losses Deepen GeneDx Holdings Q1 2026 Earnings Significant EPS Miss Shares Decline Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports WiderThanExpected Loss